QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,825 signal articles · 280 in last 24h · 109,462 total before filter · latest 1h ago
280last 24h
2532last 7d
472● bullish (7d)
240● bearish (7d)
202publishers
AllMacro234Earnings1564M&A108Regulatory19Product14Analyst24
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Investing.com17d agobullish
Verizon shares rise on earnings beat, raised guidance

Investing.com -- Verizon Communications Inc (NYSE:VZ) on Friday reported second quarter results that exceeded adjusted earnings expectations while revenue fell short of analyst estimates, with shares rising 2.7% following the announcement.

SLB (NYSE:SLB) Beats Expectations in Strong Q2 CY2026
StockStory17d agobullish
SLB (NYSE:SLB) Beats Expectations in Strong Q2 CY2026

Oilfield services provider SLB (NYSE:SLB) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 4.5% year on year to $8.97 billion. Its non-GAAP profit of $0.55 per share was 6.1% above analysts’ consensus estimates.

Intel shares rise after AI-driven revenue beats expectations and outlook improves
InvestorsHub17d agobullish
Intel shares rise after AI-driven revenue beats expectations and outlook improves

Intel (NASDAQ:INTC) shares climbed more than 4% in premarket trading on Friday after the semiconductor company posted its fastest quarterly revenue growth in over 15 years and issued stronger guidance for the current quarter, highlighting continued momentum from artificial intelligence investment. The latest results exceeded Wall Street forecasts and reinforced investor confidence that Intel’s turnaround strategy is gaining traction under Chief Executive Lip-Bu Tan.

Moody's (MCO) Earnings Beat Puts Valuation Back In Focus
Simply Wall St.18d agobullish
Moody's (MCO) Earnings Beat Puts Valuation Back In Focus

Moody's (MCO) is back in focus after reporting second quarter results that exceeded market expectations, lifting full year guidance and pairing that update with a larger share repurchase plan. See our latest analysis for Moody's. The earnings beat and guidance upgrade come after a choppy few months for Moody's, with the share price down 9.01% over the past week but still showing a 3.55% 90 day share price return and a 37.73% three year total shareholder return. This suggests that longer term...

West Pharmaceutical Services Q2 Earnings Call Highlights
MarketBeat18d agoneutral
West Pharmaceutical Services Q2 Earnings Call Highlights

West Pharmaceutical Services (NYSE:WST) raised its full-year 2026 outlook after reporting second-quarter results that topped management’s expectations, supported by strong demand for high-value product components, biologics-related offerings and GLP-1 elastomers. Chief Executive Officer and Board C